We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Variants

News List

Scientists call for investment into novel, potentially pan-virus vaccines to prevent the next pandemic europeanpharmaceuticalreview
February 25, 2021
Investment into vaccines based on broadly neutralising antibodies could allow pan-virus vaccines to be developed and stockpiled before the next pandemic, say researchers.
Gilead's Veklury should be effective against COVID-19 variants pharmatimes
January 25, 2021
Gilead Sciences has released a statement regarding the efficacy of its antiviral treatment Veklury (remdesivir), maintaining confidence in the its continued benefit against new COVID-19 variants.
Study suggests Pfizer/BioNTech vaccine effective against Covid-19 variants pharmaceutical-technology
January 11, 2021
New research suggests that Pfizer/BioNTech’s mRNA Covid-19 vaccine, BNT162b2, protects against two variants of SARS-CoV-2, the virus that causes Covid-19, that have emerged in the UK and South Africa.
New Gene Variants for Type 2 Diabetes Found drugs
May 24, 2019
New Gene Variants for Type 2 Diabetes Found.

Previous page 1 2 Next page